MedTrace Logo

Comparison of Rosuvastatin With Atorvastatin in Chronic Periodontitis

NCT02600520 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2015-11-13

No results posted yet for this study

Summary

The present study is designed as a single-centre, randomized, controlled clinical trial to evaluate and compare the clinical and radiographic efficacy of two local drug delivery systems containing 1.2% RSV gel and 1.2% ATV gel in treatment of intrabony defects in patients with chronic periodontitis as an adjunct to SRP.

Conditions

  • Chronic Periodontitis

Interventions

DRUG

SRP with RSV gel LDD

After SRP, 1.2% Rosuvastatin (RSV) gel was delivered subgingivally into the pocket

DRUG

SRP with ATV gel LDD

After SRP, 1.2% Atorvastatin (ATV) gel was delivered subgingivally into the pocket

DRUG

SRP with placebo gel LDD

After SRP, placebo gel was delivered subgingivally into the pocket

Sponsors & Collaborators

  • Government Dental College and Research Institute, Bangalore

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-05-31
Completion
2015-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02600520 on ClinicalTrials.gov